How to Set a Healthcare Company Valuation Range Without Anchoring Too Low
How to Set a Healthcare Company Valuation Range Without Anchoring Too Low Key Takeaways Why Low Anchors Hurt Many healthcare owners open with a cautious number to appear reasonable. That instinct often backfires. A soft range can signal uncertainty, invite aggressive counter-positioning, and reduce pricing tension before the process begins. MedBridge highlights this clearly in […]
Read More
How to Sell a Healthcare Company When Interest Rates Make Buyers More Cautious
How to Sell a Healthcare Company When Interest Rates Make Buyers More Cautious Key Takeaways Why Rising Interest Rates Change the Rules of Healthcare M&A For more than a decade, low-cost capital fueled aggressive acquisition activity in healthcare. Private equity firms deployed record amounts of capital into physician groups, dental platforms, behavioral health operators, and […]
Read More
How to Healthcare Company De-Risk Reimbursement Changes Before You Go to Market
How to Healthcare Company De-Risk Reimbursement Changes Before You Go to Market Key Takeaways Why Reimbursement Risk Is the Silent Deal Breaker When healthcare founders prepare to go to market, they often focus on growth metrics, provider expansion, and patient acquisition. What many underestimate is how deeply reimbursement stability influences buyer confidence. Reimbursement is not […]
Read More
Reimbursement Risk From a CEO’s Seat: What M&A Advisors Flag Before Buyers Do
Reimbursement Risk From a CEO’s Seat: What M&A Advisors Flag Before Buyers Do Key Takeaways Understanding Reimbursement Risk in Healthcare M&A For CEOs navigating a potential sale or merger, reimbursement risk is more than just a number on a balance sheet—it’s a key driver of deal value and buyer confidence. In healthcare, reimbursement risk refers […]
Read More